Recent advances in the pharmacotherapy of cocaine dependence

Current Psychiatry Reports

Volumn 6, Issue 5, 2004, Pages 323-331

  Dackis, Charles A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ACETYLCHOLINE; AMANTADINE; AMPA RECEPTOR ANTAGONIST; BACLOFEN; BROMOCRIPTINE; BUPRENORPHINE; COCAINE; DISULFIRAM; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; GABAPENTIN; GLUTAMATE RECEPTOR ANTAGONIST; MEMANTINE; METHADONE; MODAFINIL; NALTREXONE; NORADRENALIN; OLANZAPINE; OPIATE; PERGOLIDE; PROPRANOLOL; SELEGILINE; SEROTONIN; TIAGABINE; TOPIRAMATE; TRIAZOLAM; UNINDEXED DRUG; VACCINE; VENLAFAXINE;

ANOREXIA; CLINICAL TRIAL; COCAINE DEPENDENCE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; DRUG SELF ADMINISTRATION; DRUG TOLERABILITY; EUPHORIA; HUMAN; HYPERKINESIA; MEDICAL RESEARCH; MOOD DISORDER; NONHUMAN; PHARMACOLOGICAL BLOCKING; PREFRONTAL CORTEX; REVIEW; SEX; SEXUAL AROUSAL; STRESS; TACHYCARDIA; TREATMENT OUTCOME; WAKEFULNESS; WITHDRAWAL SYNDROME;

EID: 9944237269     PISSN: 15233812     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11920-004-0018-8     Document Type: Review

References (85)

1. Kampman KM, Alterman AI, Volpicelli JR, et al.: Cocaine withdrawal symptoms and initial urine toxicology results predict treatment attrition in outpatient cocaine dependence treatment. Psychol Addict Behav 2001, 15:52-59.
2. Dackis CA, Gold MS: New concepts in cocaine addiction: the dopamine depletion hypothesis. Neurosci Biobehav Rev 1985, 9: 69-477.
3. Dackis CA, O'Brien CP: Cocaine dependence: a disease of the brain's reward centers. J Subst Abuse Treat 2001, 21: 11-117.
4. Garlow SJ, Purselle D, D'Orio B: Cocaine use disorders and suicidal ideation. Drug Alcohol Depend 2003, 70:101-104.
5. Sofuoglu M, Dudish-Poulsen S, Brown S, et al.: Association of cocaine withdrawal symptoms with more severe dependence and enhanced subjective response to cocaine. Drug Alcohol Depend 2003, 69:273-282.
6. Newton TE, Kalechstein AD, Tervo KE, et al.: Irritability following abstinence from cocaine predicts euphoric effects of cocaine administration. Addict Behav 2003, 28:817-821.
7. Sofuoglu M, Brown S, Babb DA, et al.: Depressive symptoms modulate the subjective and physiological response to cocaine in humans. Drug Alcohol Depend 2001, 63:131-137.
8. Dackis CA, O'Brien CP: The neurobiology of addiction. In Diseases of the Nervous System. Edited by Asbury A. Cambridge: Cambridge University Press; 2001:431-444.
9. Volkow ND, Fowler JS, Wang GJ: Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans. J Psychopharmacol 1999, 13:337-345.
10. Rocha BA: Stimulant and reinforcing effects of cocaine in monoamine transporter knockout mice. Eur J Pharmacol 2003, 479:107-115.
11. Kampman KM, Pettinati H, Lynch KG, et al.: A pilot trial of olanzapine for the treatment of cocaine dependence. Drug Alcohol Depend 2003, 70:265-273.
12. Haney M, Ward AS, Foltin RW, et al.: Effects of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administration by humans. Psychopharmacology (Berl) 2001, 155:330-337.
13. Dackis CA, O'Brien CP: Cocaine dependence: the challenge for pharmacotherapy. Curr Opinion Psychiatry 2002, 15: 61-268.
14. Dackis C, O'Brien C: Glutamatergic agents for cocaine dependence. Ann NY Acad Sci 2003, 1003: 328-345.
15. Chiamulera C, Epping-Jordan MP, Zocchi A, et al.: Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice. Nat Neurosci 2001, 4:873-874.
16. Chuhma N, Zhang H, Masson J, et al.: Dopamine neurons mediate a fast excitatory signal via their glutamatergic synapses J Neurosci 2004, 24:972-981.
17. Collins ED, Vosburg SK, Hart CL, et al.: Amantadine does not modulate reinforcing, subjective, or cardiovascular effects of cocaine in humans. Pharmacol Biochem Behav 2003, 76: 01-407.
18. Collins ED, Ward AS, McDowell DM, et al.: The effects of memantine on the subjective, reinforcing and cardiovascular effects of cocaine in humans. Behav Pharmacol 1998, 9: 87-598.
19. Dackis CA, Lynch KG, Yu E, et al.: Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study. Drug Alcohol Depend 2003, 70:29-37.
20. Malcolm I, Donovan JL, DeVane CL, et al.: Influence of modafinil, 400 or 800 mg/day on subjective effects of intravenous cocaine in non-treatment seeking volunteers. In College on Problems of Drug Dependence. Quebec City, 2002.
21. Baker DA, McFarland K, Lake RW, et al.: N-acetyl cysteine-induced blockade of cocaine-induced reinstatement. Ann N Y Acad Sci, 2003, 1003:349-351.
22. Kalivas PW, McFarland K, Bowers S, et al.: Glutamate transmission and addiction to cocaine. Ann N Y Acad Sci 2003, 1003:169-175.
23. Ferraro L, Antonelli T, O'Connor WT, et al.: The effects of modafinil on striatal, pallidal and nigral GARA and glutamate release in the conscious rat: evidence for a preferential inhibition of striato-pallidal GABA transmission. Neurosci Lett 1998, 253: 35-138.
24. Fadda P, Scherma M, Fresu A, et al.: Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat. Synapse 2003, 50:1-6.
25. Brebner K, Childress AR, Roberts DC: A potential role for GABA(B) agonists in the treatment of psychostimulant addiction. Alcohol Alcohol 2002, 37:478-484.
26. Lile JA, Stoops WW, Allen TS, et al.: Baclofen does not alter the reinforcing, subject-rated or cardiovascular effects of intranasal cocaine in humans. Psychopharmacology (Berl) 2004, 171:441-449.
27. Haga JL, Baker RW, Rush CR: Behavioral and physiological effects of cocaine in humans following triazolam. Pharmacol Biochem Behav 2003, 76:383-392.
28. Hart CL, Ward AS, Collins ED, et al.: Gabapentin maintenance decreases smoked cocaine-related subjective effects, but not self-administration by humans. Drug Alcohol Depend 2004, 73: 79-287.
29. Zhang Y, Schlussman SD, Ho A, et al.: Effect of chronic "binge cocaine" on basal levels and cocaine-induced increases of dopamine in the caudate putamen and nucleus accumbens of C57BL/6J and 129/J mice. Synapse 2003, 50:191-199.
30. Houtsmuller EJ, Notes LD, Newton T, et al.: Transdermal selegiline and intravenous cocaine: safety and interactions Psychopharmacology (Berl) 2004, 172:31-40.
31. Mateo Y, Budygin EA, John CE, et al.: Role of serotonin in cocaine effects in mice with reduced dopamine transporter function. Proc Natl Acad Sci U S A 2004, 101:372-377.
32. Smith JE, Co C, Yin X, et al.: Involvement of cholinergic neuronal systems in intravenous cocaine self-administration Neurosci Biobehav Rev 2004, 27:841-850.
33. Bowen CA, Negus SS, Zong R, et al.: Effects of mixed-action kappa/mu opioids on cocaine self-administration and cocaine discrimination by rhesus monkeys. Neuropsychopharmacology 2003, 28:1125-1139.
34. Sofuoglu M, Singha A, Kosten TR, et al.: Effects of naltrexone and isradipine, alone or in combination, on cocaine responses in humans. Pharmacol Biochem Behav 2003, 75:801-808.
35. Walsh SL, Sullivan JT, Preston KL, et al.: Effects of naltrexone on response to intravenous cocaine, hydromorphone and their combination in humans. J Pharmacol Exp Ther 1996, 279: 24-538.
36. Montoya ID, Gorelick DA, Preston KL, et al.: Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence. Clin Pharmacol Ther 2004, 75:34-48.
37. Foltin RW, Ward AS, Collins ED, et al.: The effects of venlafaxine on the subjective, reinforcing, and cardiovascular effects of cocaine in opioid-dependent and non-opioid-dependent humans. Exp Clin Psychopharmacol 2003, 11:123-130.
38. Ahmed SH, Kenny PJ, Koob GF, et al.: Neurobiological evidence for hedonic allostasis associated with escalating cocaine use Nat Neurosci 2002, 5:625-626.
39. Kalivas PW, McFarland K: Brain circuitry and the reinstatement of cocaine-seeking behavior. Psychopharmacology (Berl) 2003, 168:44-56.
40. Schultz W: Reward signaling by dopamine neurons. Neuroscientist 2001, 7:293-302.
41. Carelli RM, Wondolowski J: Selective encoding of cocaine versus natural rewards by nucleus accumbens neurons is not related to chronic drug exposure. J Neurosci 2003, 23:11214-11223.
42. Koeltzow TE, White FJ: Behavioral depression during cocaine withdrawal is associated with decreased spontaneous activity of ventral tegmental are dopamine neurons. Behav Neurosci 2003, 117:860-865.
43. Thomas MJ, Beurrier C, Bonci A, et al.: Long-term depression in the nucleus accumbens: a neural correlate of behavioral sensitization to cocaine. Nat Neurosci 2001, 4:1217-1223.
44. Xi ZX, Ramamoorthy S, Shen H, et al.: GABA transmission in the nucleus accumbens is altered after withdrawal from repeated cocaine. J Neurosci 2003, 23:3498-3505.
45. Baker DA, McFarland K, Lake RW, et al.: Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse Nat Neurosci 2003, 6:743-749.
46. Ferraro L, Tanganelli S, O'Connor WT, et al.: The vigilance promoting drug modafinil increases dopamine release in the rat nucleus accumbens via the involvement of a local GABAergic mechanism. Eur J Pharmacol 1996, 306:33-39.
47. Dackis C, Kampman K, Lynch K, et al.: Modafinil improves cocaine abstinence in cocaine dependence: a double-blind, placebo-controlled trial. In New Clinical Drug Evaluation Unit (NCDEU). Phoenix, AR, 2004.
48. Beusterien KM, Rogers AE, Walsleben JA, et al.: Health-related quality of life effects of modafinil for treatment of narcolepsy. Sleep 1999, 22:757-765.
49. Kaufman JN, Ross TJ, Stein EA, et al.: Cingulate hypoactivity in cocaine users during a GO-NOGO task as revealed by event-related functional magnetic resonance imaging. J Neurosci 2003, 23:7839-7843.
50. Matochik JA, London ED, Eldreth DA, et al.: Frontal cortical tissue composition in abstinent cocaine abusers: a magnetic resonance imaging study. Neuroimage 2003, 19:1095-1102.
51. Franklin TR, Acton PD, Maldjian JD, et al.: Decreased gray matter concentration in the insular, orbitofrontal, cingulate, and temporal cortices of cocaine patients. Biol Psychiatry 2002, 51:134-142.
52. Lidow MS, Song ZM: Primates exposed to cocaine in utero display reduced density and number of cerebral cortical neurons. J Comp Neurol 2001, 435:263-275.
53. Trantham H, Szumlinski KK, McFarland K, et al.: Repeated cocaine administration alters the electrophysiological properties of prefrontal cortical neurons. Neuroscience 2002, 113:749-753.
54. Robinson TE, Gorny G, Mitton E, et al.: Cocaine self-administration alters the morphology of dendrites and dendritic spines in the nucleus accumbens and neocortex. Synapse 2001, 39:257-266.
55. Walton ME, Bannermman KA, Alterescue K, et al.: Functional specialization within medial frontal cortex of the anterior cingulate for evaluating effort-related decisions. J Neurosci 2003, 23:6475-6479.
56. Arana FS, Parkinson JA, Hinton E, et al.: Dissociable contributions of the human amygdala and orbitofrontal cortex to incentive motivation and goal selection. J Neurosci 2003, 23:9632-9638.
57. Rolls ET: The orbitofrontal cortex and reward. Cereb Cortex 2000, 10:284-294.
58. Grimm JW, Lu L, Hayashi T, et al.: Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving. J Neurosci 2003, 23: 42-747.
59. Scammell TE, Estabrooke IV, McCarthy MT, et al.: Hypothalamic arousal regions are activated during modafinil-induced wakefulness. J Neurosci 2000, 20:8620-8628.
60. Turner DC, Robbins TW, Clark L, et al.: Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology (Berl) 2003, 165:260-269.
61. Garavan H, Pankiewicz J, Bloom A, et al.: Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli. Am J Psychiatry 2000, 157:1789-1798.
62. Ghitza UE, Fabbricatore AR, Prokopenko V, et al.: Persistent cue-evoked activity of accumbens neurons after prolonged abstinence from self-administered cocaine. J Neurosci 2003, 23:7239-7245.
63. Hayes RJ, Vorel SR, Spector J, et al.: Electrical and chemical stimulation of the basolateral complex of the amygdala reinstates cocaine-seeking behavior in the rat. Psychopharmacology (Berl) 2003, 168:75-83.
64. Carelli RM, Williams JG, Hollander JA: Basolateral amygdala neurons encode cocaine self-administration and cocaine-associated cues. J Neurosci 2003, 23:8204-8211.
65. Di Ciano P, Everitt BJ: Dissociable effects of antagonism of NMDA and AMPA/KA receptors in the nucleus accumbens core and shell on cocaine-seeking behavior. Neuropsychopharmacology 2001, 25: 41-360.
66. Hotsenpiller G, Wolf ME: Baclofen attenuates conditioned locomotion to cues associated with cocaine administration and stabilizes extracellular glutamate levels in rat nucleus accumbens. Neuroscience 2003, 118:123-134.
67. Kampman K, Pettinati H, Lynch K, et al.: A pilot trial of topiramate for the treatment of cocaine dependence. Drug Alcohol Depend 2004, 70:265-27.
68. Weiss F, Maldonado-Vlaar CS, Parsons EL, et al.: Control of cocaine-seeking behavior by drug-associated stimuli in rats: effects on recovery of extinguished operant-responding and extracellular dopamine levels in amygdala and nucleus accumbens. Proc Natl Acad Sci U S A 2000, 97:4321-4326.
69. Neisewander JL, O'Dell LE, Tran-Nguyen LT, et al.: Dopamine overflow in the nucleus accumbens during extinction and reinstatement of cocaine self-administration behavior. Neuropsychopharmacology 1996, 15:506-514.
70. Di Ciano P, Everitt BJ: The GABA(B) receptor agonist baclofen attenuates cocaine- and heroin-seeking behavior by rats. Neuropsychopharmacology 2003, 28:510-518.
71. Shoptaw S, Yang Y, Rotheram-Fuller EJ, et al.: Randomized placebo-controlled trial of baclofen for cocaine dependence: preliminary effects for individuals with chronic patterns of cocaine use J Clin Psychiatry 2003, 64:1440-1448.
72. McFarland K, Lapish CC, Kalivas PW: Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior. J Neurosci 2003, 23: 531-3537.
73. Erb S, Salmaso N, Rodaros D, et al.: A role for the CRF-containing pathway from central nucleus of the amygdala to bed nucleus of the stria terminalis in the stress-induced reinstatement of cocaine seeking in rats. Psychopharmacology (Berl) 2001, 158: 0-65.
74. Gryder DS, Rogawski MA: Selective antagonism of GluR5 kainate-receptor-mediated synaptic currents by topiramate in rat basolateral amygdala neurons. J Neurosci 2003, 23: 069-7074.
75. Brodie JD, Figueroa E, Dewey SL: Treating cocaine addiction: from preclinical to clinical trial experience with gamma-vinyl GABA. Synapse 2003, 50:261-265.
76. Gonzalez G, Sevarino K, Sofuoglu M, et al.: Tiagabine increases cocaine-free urines in cocaine-dependent methadone-treated patients: results of a randomized pilot study. Addiction 2003, 98:1625-1632.
77. Volkow ND, Wang J, Fowler S, et al.: Enhanced sensitivity to benzodiazepines in active cocaine-abusing subjects: a PET study. Am J Psychiatry 1998, 155:200-206.
78. Shoptaw S, Kintaudi PC, Charuvastra C, et al.: A screening trial of amantadine as a medication for cocaine dependence. Drug Alcohol Depend 2002, 66:217-224.
79. Carroll KM, Fenton LR, Ball SA, et al.: Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial. Arch Gen Psychiatry 2004, 61:264-272.
80. Haile CN, During MJ, Jatlow PI, et al.: Disulfiram facilitates the development and expression of locomotor sensitization to cocaine in rats. Biol Psychiatry 2003, 54:915-921.
81. Ross MW, Hwang LY, Zack C, et al.: Sexual risk behaviours and STIs in drug abuse treatment populations whose drug of choice is crack cocaine. Int J STD AIDS 2002, 13:769-774.
82. Andersen ML, Tufik S: Distinct effects of paradoxical sleep deprivation and cocaine administration on sexual behavior in male rats. Addict Biol 2002, 7:251-253.
83. Hu M, Crombag HS, Robinson TE, et al.: Biological basis of sex differences in the propensity to self-administer cocaine. Neuropsychopharmacology 2004, 29:81-85.
84. Balfour ME, Yu L, Coolen LM: Sexual behavior and sex-associated environmental cues activate the mesolimbic system in male rats. Neuropsychopharmacology 2004, 29:718-730.
85. Carelli RM, Ijames SG, Crumling AJ: Evidence that separate neural circuits in the nucleus accumbens encode cocaine versus "natural" (water and food) reward. J Neurosci 2000, 20: 255-4266.